Newsfeeds - Spark Newswire

1 minute read

NanoViricides Starts Drug Development Program For Recent Cases Of Unexplained Pediatric Hepatitis

Today, 11:30 AM

NanoViricides Inc (NYSE:NNVC) has initiated a program to screen its library of broad-spectrum antiviral nanoviricides against human Adenovirus 41 Type F…

NNVC

1 minute read

NanoViricides Reports that It Has Begun Drug Development To Combat Recent Cases Of Severe Pediatric Hepatitis

By Benzinga Newsdesk

Today, 11:30 AM

NanoViricides, Inc. (NYSE:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform reports that it has begun drug development to

NNVC

44 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 11:30 AM

On Wednesday, 807 companies reached new 52-week lows.

AADI

1 minute read

Trading Ideas

Watching Bird Flu-Related Stocks Following Report ‘U.S. reports its first human case of H5 bird flu’: BioCryst, NanoViricides, iBio, Inovio

By Benzinga Newsdesk

Today, 11:30 AM

https://www.reuters.com/world/us/us-reports-its-first-human-case-h5-bird-flu-2022-04-29/

BCRX

32 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 11:30 AM

On Thursday, 615 stocks hit new 52-week lows.

AAOI

1 minute read

EXCLUSIVE: NanoViricides Develops Chewable Pills, Lung Inhalation Formulations For COVID-19 Candidate

By Vandana Singh

Today, 11:30 AM

NanoViricides Inc (NYSE: NNVC) has developed oral gummies formulations of its Pan-Coronavirus COVID-19 Drug Candidate NV-CoV-2 to benefit non-hospitalized patients.

NNVC

1 minute read

News

NanoViricides Highlights Filing Of 10-K

By Bill Haddad

Today, 11:30 AM

NanoViricides, Inc. (NYSE:NNVC) (the "Company"), reports that it has filed its Annual Report on Form 10-K for the fiscal year ending June 30, 2021 with the Securities and Exchange Commission (SEC) on

NNVC

6 minute read

NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus Activity

By NanoViricides

Today, 11:30 AM

Shelton, Connecticut -- (October 11, 2021) - NanoViricides, Inc.

NNVC

3 minute read

NanoViricides Leaps Forward in its Quest to Defeat COVID-19

By Kim Griffin

Today, 11:30 AM

Photo by Louis Reed on Unsplash

GILD

3 minute read

31 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 11:30 AM

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 54.1% to $3.6998 after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from NASA to provide drone and rover software, hardware, and support for the Simulated Mars mission.

APOP